Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Nov 3, 2025, 4:00 PM EST
1.200
+0.020 (1.69%)
After-hours: Nov 3, 2025, 4:30 PM EST
ALLO's stock price has decreased by -56.25% in the past year and price targets may not have had time to catch up.
Allogene Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$8.80
Upside
+645.76%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Oct 10, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 4, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 4, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +493.22% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +238.98% | May 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $10 | Strong Buy | Maintains | $14 → $10 | +747.46% | May 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +493.22% | May 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +747.46% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +662.71% | May 14, 2025 |
| Baird | Baird | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +662.71% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +577.97% | Mar 19, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,086.44% | Mar 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +747.46% | Mar 14, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +323.73% | Mar 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $9 | Buy | Maintains | $11 → $9 | +662.71% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +747.46% | Nov 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.